BioCentury
ARTICLE | Clinical News

AVN-101: Phase I started

April 13, 2009 7:00 AM UTC

Avineuro began an open-label, placebo-controlled, Russian Phase I trial to evaluate oral AVN-101 in 16 healthy volunteers. ...